Serum testosterone as a predictive biomarker: results from a randomised clinical trial comparing enzalutamide and abiraterone acetate in men with metastatic castration-resistant prostate cancer
Ternov, K. K., Fode, M., Sønksen, J. O. R., Bisbjerg, R., Lindberg, H., Palapattu, G., Bratt, O. & Østergren, P. B., nov. 2023.
Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review